SAN DIEGO (AP) _ Organovo Holdings Inc. (ONVO) on Wednesday reported a loss of $10.7 million in its fiscal fourth quarter.
On a per-share basis, the San Diego-based company said it had a loss of 10 cents.
The development-stage company focused on commercializing functional human tissue for drug and biological research posted revenue of $812,000 in the period.
For the year, the company reported that its loss narrowed to $38.4 million, or 39 cents per share. Revenue was reported as $4.2 million.
Organovo expects full-year revenue in the range of $6 million to $8.5 million.
In the final minutes of trading on Wednesday, the company's shares hit $2.83. A year ago, they were trading at $3.01.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ONVO at https://www.zacks.com/ap/ONVO
Keywords: Organovo, Earnings Report